Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM
Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes
ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in...
Type 2 diabetes and hypertension were the major contributors to chronic kidney disease-related deaths among women in 2021
Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
Women with persistently high VMS have increased risk for diabetes versus those with persistently low VMS
Potential Genetic Link ID’d Between Thyroid Disease, Alopecia Areata
Significant genetic predictions of alopecia seen with hypothyroidism, Hashimoto thyroiditis, and subacute thyroiditis
AI Can Help ID Patients With Diabetes at Highest Risk for Cardiomyopathy
Authors say these identified patients may benefit from more aggressive heart failure preventive strategies
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity
Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay
Financial precarity more prevalent among Black and Hispanic versus White, those with less versus more than high school education
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1...
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity